Kaken Pharmaceutical Company, Ltd.

Hirokuni Kogetsu

Akiko Ochiai

Yasutomi Kato

Kiyoshi Maruyama

The preparation for intranasal administration comprising D-alanyl-3-(naphthalen-2-yl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide (pralmorelin) and/or an acid addition salt thereof as an active ingredient and water permits a marked increase in the in vivo absorption of pralmorelin and hence provides adequate efficacy even if it is administered in a small dose at a time. The preparation also allows pralmorelin to be dissolved in an increased amount, so it can be formulated pharmaceutically with great ease. It also high stability over time.

Growing community of inventors

Shizuoka, Japan

Hirokuni Kogetsu